Leerink Partnrs Expects Lower Earnings for Arcus Biosciences
Arcus Biosciences, Inc. (NYSE:RCUS – Free Report) – Analysts at Leerink Partnrs reduced their Q1 2025 earnings per share (EPS) estimates for Arcus Biosciences in a research report issued to clients and investors on Wednesday, February 26th. Leerink Partnrs analyst D. Graybosch now forecasts that the company will post earnings of ($1.13) per share for […]
Arcus Biosciences, Inc. (NYSE:RCUS – Free Report) – Analysts at Leerink Partnrs reduced their Q1 2025 earnings per share (EPS) estimates for Arcus Biosciences in a research report issued to clients and investors on Wednesday, February 26th. Leerink Partnrs analyst D. Graybosch now forecasts that the company will post earnings of ($1.13) per share for […]
